CD4 and HIV-1 infection: Concerning the presence/absence of RASs, the patients without RASs underwent a longer period of HIV-1 treatment and longer duration of HIV-1 infection, higher liver stiffness assessed by transient elastography, more preserved immune status (assessed by CD4 T cell count and CD4/CD8 ratio), and lower HCV-RNA viremia with respect to patients with RASs.